PharmaCyte Biotech PMCB Q1 2026 Earnings Narrowing Loss Amid Strategic Pipeline Progress FGSN Q1 2026 Earnings Earnings Miss Sends Notes Lower Leslies Inc Q1 2026 Earnings Significant EPS Miss Despite Strong Stock Rally ATNM Q1 2026 Earnings NarrowerthanExpected Loss Highlights Controlled Spending Amid Clinical Progress ACNT Q1 2025 Earnings EPS Misses Estimates Amid Market Challenges Vistagen Therapeutics VTGN Q1 2026 Earnings Narrowing Loss Beats Estimates as Pipeline Progress Continues